Search - tctmd.com

Displaying 481 - 500 of 4251

Sort: Relevancy | Date

Presentation TVT 2016

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

Presenter: Chet Rihal

June 17, 2016

Presentation TVT 2016

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

Presenter: Azeem Latib

June 17, 2016

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

AS and the Failing Bioprosthetic Mitral Valve

Presenter: Mathew Williams

June 17, 2016

Presentation TVT 2016

Anatomy of Heavily Calcified Aortic Valve

Presenter: Danny Dvir

June 17, 2016

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

Severe LVOT Calcification and TAVR: Assessment and Procedural Decision Making

Presenter: Hasan Jilaihawi

June 17, 2016

Presentation TVT 2016

PARTNER Echocardiography Observations on Valve Durability

Presenter: Rebecca T. Hahn

June 17, 2016

Presentation TVT 2016

Standard and Dedicated Guidewires and Sheaths for TAVR Procedures

Presenter: Torsten P. Vahl

June 17, 2016

Presentation TVT 2016

Severe LV Dysfunction and Severe AS: Diagnostic Tests and Procedural Choices

Presenter: Howard C. Herrmann

June 17, 2016

Presentation TVT 2016

Anatomy of Effaced Sinuses/Calcification

Presenter: Creighton W. Don

June 17, 2016

Presentation TVT 2016

A Surgeons Perspective on Bioprosthetic Valve Durability and Structural Valve Deterioration

Presenter: Hendrik Treede

June 17, 2016

Presentation TVT 2016

Access Site Management Strategies, Including New Large-Hole Closure Devices - 2

Presenter: Alexandre Abizaid

June 17, 2016

Presentation TVT 2016

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Access Site Management Strategies, Including New Large-Hole Closure Devices - 1

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

Identifying the Futile AS Patient: When Are Extreme Comorbidities Too Much for TAVR?

Presenter: David J. Cohen

June 17, 2016

Presentation TVT 2016

Anatomy of a Small LVOT/Annulus

Presenter: James M. McCabe

June 17, 2016

Presentation TVT 2016

Strategies and Timing of PCI in Patients With CAD Undergoing TAVR: Results From a Large Single-Center Experience

Presenter: Torsten P. Vahl

June 17, 2016

Advertisement

An Update on Subclinical Bioprosthetic Leaflet Thickening and Thrombosis: Possible Effects on TAVR Durability

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

The Incidence, Diagnosis, Impact, and Treatment of Valve Thrombosis After TAVR

The Sentinel US Pivotal Clinical Trial Design

AS and the Failing Bioprosthetic Mitral Valve

Anatomy of Heavily Calcified Aortic Valve

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Severe LVOT Calcification and TAVR: Assessment and Procedural Decision Making

PARTNER Echocardiography Observations on Valve Durability

Standard and Dedicated Guidewires and Sheaths for TAVR Procedures

Severe LV Dysfunction and Severe AS: Diagnostic Tests and Procedural Choices

Anatomy of Effaced Sinuses/Calcification

A Surgeons Perspective on Bioprosthetic Valve Durability and Structural Valve Deterioration

Access Site Management Strategies, Including New Large-Hole Closure Devices - 2

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Access Site Management Strategies, Including New Large-Hole Closure Devices - 1

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Identifying the Futile AS Patient: When Are Extreme Comorbidities Too Much for TAVR?

Anatomy of a Small LVOT/Annulus

Strategies and Timing of PCI in Patients With CAD Undergoing TAVR: Results From a Large Single-Center Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content